Javascript must be enabled to continue!
A web site page for information about Osteonecrosis of Jaw (ONJ): the Rete Oncologica Piemonte e Valle d'Aosta experience, at www.reteoncologica.it
View through CrossRef
Osteonecrosis of the Jaw (ONJ) related to drugs (bisphosphonates, denosumab, antiangiogenic and other agents) is an issue of care by the “Rete Oncologica di Piemonte e Valle d’Aosta” since 2005. The “Rete Oncologica” is a cancer network that include professionals (physicians, nurses, technicians, supporting staff, data managers, etc) of all the healthcare units that manage and treat patients with cancer and hematologic disorders in two regions (Piedmont and Aosta Valley, globally 4.4 million population) in the North-Western Italy. Besides study groups, research grants and organization of meetings, in order to facilitate the awareness of ONJ issues, on 2014 the network created specific ONJ-dedicated pages on the network website www.reteoncologica.it [http://www.reteoncologica.it] . In the area for healthcare staff , the reader can find an ONJ title, that opens to a ONJ front page (http://www.reteoncologica.it/area-operatori/osteonecrosi-dei-mascellari-onj) presenting links to recent issues (recommendations, meetings, papers, etc) and to an Archive with previous contents, classified for year (http://www.reteoncologica.it/area-operatori/osteonecrosi-dei-mascellari-onj/185-documenti-e-slide) . Preliminary altmetric evaluation of the ONJ pages (number of visits; median time of stay; etc) show a variable but steady access to the ONJ contents of the website, with occasional peaks.
Title: A web site page for information about Osteonecrosis of Jaw (ONJ): the Rete Oncologica Piemonte e Valle d'Aosta experience, at www.reteoncologica.it
Description:
Osteonecrosis of the Jaw (ONJ) related to drugs (bisphosphonates, denosumab, antiangiogenic and other agents) is an issue of care by the “Rete Oncologica di Piemonte e Valle d’Aosta” since 2005.
The “Rete Oncologica” is a cancer network that include professionals (physicians, nurses, technicians, supporting staff, data managers, etc) of all the healthcare units that manage and treat patients with cancer and hematologic disorders in two regions (Piedmont and Aosta Valley, globally 4.
4 million population) in the North-Western Italy.
Besides study groups, research grants and organization of meetings, in order to facilitate the awareness of ONJ issues, on 2014 the network created specific ONJ-dedicated pages on the network website www.
reteoncologica.
it [http://www.
reteoncologica.
it] .
In the area for healthcare staff , the reader can find an ONJ title, that opens to a ONJ front page (http://www.
reteoncologica.
it/area-operatori/osteonecrosi-dei-mascellari-onj) presenting links to recent issues (recommendations, meetings, papers, etc) and to an Archive with previous contents, classified for year (http://www.
reteoncologica.
it/area-operatori/osteonecrosi-dei-mascellari-onj/185-documenti-e-slide) .
Preliminary altmetric evaluation of the ONJ pages (number of visits; median time of stay; etc) show a variable but steady access to the ONJ contents of the website, with occasional peaks.
Related Results
Novedades sobre el enterramiento femenino de la Primera Edad del Hierro de Casa del Carpio (Belvís de la Jara, Toledo)
Novedades sobre el enterramiento femenino de la Primera Edad del Hierro de Casa del Carpio (Belvís de la Jara, Toledo)
Las características de la ubicación de la tumba de Casa del Carpio (Belvís de la Jara, Toledo), las circunstancias de su documentación, y lo excepcional del ajuar documentado han c...
Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.
Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.
Survival of cancer and myeloma patients after diagnosis of medication-related Osteonecrosis of Jaws (ONJ) has not adequately been reported. ONJ is not rare in patients with bone me...
Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab: A Case Series from the FDA Adverse Event Reporting System (FAERS) Database
Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab: A Case Series from the FDA Adverse Event Reporting System (FAERS) Database
Abstract
Introduction:
Osteonecrosis of the jaw (ONJ) is a rare but serious adverse drug reaction (ADR) historically associated with denosumab and bisphosphonate therapy. S...
Medication-Induced Osteonecrosis of the Jaw: A Review of Cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Medication-Induced Osteonecrosis of the Jaw: A Review of Cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
Abstract
Introduction:Osteonecrosis of the jaw (ONJ) is a rare but serious adverse drug reaction (ADR) commonly associated with bisphosphonate and denosumab therapy. Prior ...
Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Abstract
Introduction
Osteonecrosis, also known as avascular necrosis, aseptic necrosis, or ischemic necrosis, results from a temporary or permanent halt in blood flow to a portion...
Osteonecrosis of the jaw associated with pamidronate therapy
Osteonecrosis of the jaw associated with pamidronate therapy
AbstractBisphosphonates are commonly used in the treatment and prevention of osteoporosis, and they are also an important therapeutic adjunct in multiple myeloma and other cancers ...
Hypofibrinolysis: A common, major cause of osteonecrosis
Hypofibrinolysis: A common, major cause of osteonecrosis
AbstractIn 30 patients with osteonecrosis of the hip (12 idiopathic, 18 secondary), we assessed the role of hypofibrinolysis mediated by high levels of piasminogen activator inhibi...
Multifocal Glucocorticoid-Associated Osteonecrosis: Clinical Characteristics and Systemic Molecular Features
Multifocal Glucocorticoid-Associated Osteonecrosis: Clinical Characteristics and Systemic Molecular Features
Background: Multifocal osteonecrosis involving three or more anatomical sites is an uncommon but severe manifestation of glucocorticoid-associated osteonecrosis and may be associat...

